Allopurinol kinetics and bioavailability - Intravenous, oral and rectal administration

Steven J. Appelbaum, Michael Mayersohn, Robert T. Dorr, Donald Perrier

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Six normal, healthy adult males received a single dose of allopurinol intravenously, orally in the form of a commercial tablet, and rectally in the form of an extemperaneously prepared suppository (either in a cocoa butter or in polyethylene glycol base). Plasma allopurinol and oxipurinol concentrations were measured over a period of at least 60 h. The following mean (±SD) values were obtained from the intravenous allopurinol experiment: clearance, 9.62±3.49 ml · kg-1 · min-1; Vd, 1.61±0.74 l/kg; t1/2, 1.62 h. Oxipurinol had a mean t1/2 of 16.90 h. The absolute systemic bioavailability of the oral tablet was 67%±23%, while the allopurinol rectal suppositories produced no measurable plasma concentrations of allopurinol or oxipurinol in any of the subjects. Current use of rectal dosage forms as an adjunct in cancer chemotherapy should therefore be re-examined.

Original languageEnglish (US)
Pages (from-to)93-98
Number of pages6
JournalCancer Chemotherapy And Pharmacology
Volume8
Issue number1
DOIs
StatePublished - Apr 1982

ASJC Scopus subject areas

  • Oncology
  • Toxicology
  • Pharmacology
  • Cancer Research
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Allopurinol kinetics and bioavailability - Intravenous, oral and rectal administration'. Together they form a unique fingerprint.

  • Cite this